November 27, 2003

News Release: MDS Brings Omega-3 Fatty Acid Test to Canadians

MDS Diagnostic Services announced today that it is providing national access to a newly developed test for Omega-3 essential fatty acids.

'Consumers are becoming increasingly aware of the benefits of omega-3 fatty acids,'said Dr. Brian Sheridan, Senior Vice-President of Medical Affairs for MDS. 'Now we have a way to help patients and their physicians monitor Omega-3 levels and pro-actively manage this aspect of heart health.' The test, developed by Nutrasource Diagnostics Inc. (NDI) of Guelph, Ont., uses a small blood sample to determine an Omega-3 fatty acid score. Patients with low levels can then modify their diets to boost their results. Desirable levels of Omega-3 fatty acids have been linked with significantly reduced risk of heart disease.

'Heart disease is a leading killer of Canadians,'said William Rowe, President and CEO of NDI. 'According to the clinical literature, understanding Omega-3 levels is an essential component of cardiovascular disease risk assessment.'

For more information on Omega-3 and the testing program visit the MDS Diagnostic Services website at www.mdsdx.com. People interested in having the test performed should discuss it with their physician.

MDS Diagnostic Services is part of MDS Inc., an international health and life sciences company. In many of its products and services, it is among the largest and most respected companies in the world. MDS enhances the health of people around the world by providing laboratory testing, imaging products and research services to speed discovery and development of new drugs, therapy systems for planning and delivery of cancer treatments, analytical instruments to assist in the development of new drugs, and medical/surgical supplies. MDS employs nearly 10,000 highly skilled people in its global operations on five continents. Detailed information about the company is available at the MDS website at www.mdsintl.com or by calling 1-888-MDS-7222, 24 hours a day.

For further information: Contact Shirley Connor, Media Relations, MDS Diagnostic Services, (416) 675-6777 ext. 2141



WEBSITE This email address is being protected from spambots. You need JavaScript enabled to view it.